Chile’s health minister intends to submit a plan for a national medicines agency, the Agencia Nacional de Medicamentos (Anamed), to the country’s parliament. Anamed would preside over drug regulations, a task that currently belongs to the National Institute of Public Health, and would create and enforce bioequivalence requirements. Currently, local drugmakers can manufacture and market […]

Although Australia’s 2012 budget, revealed May 10, has been slashed by AUD 22 billion ($24 billion), funding for some research agencies has not. The budgets of the National Health and Medical Research Council, and the Australian Research Council will remain at AUD 850 million and AUD 845 million, respectively. Regional universities will receive AUD 500 […]

China’s pharmaceutical industry output is expected to grow 20% annually, surpassing CNY 3 trillion ($460.44 billion) in 2015, according to a 12th Five-Year Plan for the industry, which is slated to be published in May. According to Chinese Pharmaceutical Enterprises Association President Yu Mingde, the plan aims for the 100 manufacturers with the highest sales […]

Sri Lanka’s Health Ministry plans to establish the National Drug Quality Regulatory Authority as part of the National Drug Quality Regulatory Act, which will be delivered to Parliament by July. The Authority will fulfill the country’s need for quality testing of foreign pharmaceuticals. Currently, pharmacists randomly test drug batches. The Authority is expected to perform […]

China’s Premier Wen Jiabao stressed the importance of streamlining government science funding in his annual report at the Chinese People’s Political Consultative Conference in March. Funding for Chinese researchers is currently dependent on how many of their publications are found in Thomson Reuters’ Science Citation Index and the influence of the journals in which they […]